{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:03:05Z","timestamp":1790373785812,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10557-021-07312-w","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:30:11Z","timestamp":1649849411000},"page":"655-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3"],"prefix":"10.1007","volume":"37","author":[{"given":"Yun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-8146","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"7312_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00403-019-01975-0","volume":"311","author":"GS Park","year":"2019","unstructured":"Park GS, An MK, Yoon JH, et al. Botulinum toxin type a suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts. Arch Dermatol Res. 2019;311:807\u201314.","journal-title":"Arch Dermatol Res"},{"key":"7312_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan D, Takawale A, Lee J, Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair. 2012;5:15.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"7312_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.12965\/jer.130049","volume":"9","author":"HB Kwak","year":"2013","unstructured":"Kwak HB. Aging, exercise, and extracellular matrix in the heart. J Exerc Rehabil. 2013;9:338\u201347.","journal-title":"J Exerc Rehabil"},{"key":"7312_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0036-1586228","volume":"43","author":"P Flevaris","year":"2017","unstructured":"Flevaris P, Vaughan D. The role of plasminogen activator inhibitor Type-1 in fibrosis. Semin Thromb Hemost. 2017;43:169\u201377.","journal-title":"Semin Thromb Hemost"},{"key":"7312_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fcvm.2020.00034","volume":"7","author":"W Parichatikanond","year":"2020","unstructured":"Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H. Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-beta signaling. Front Cardiovasc Med. 2020;7:34.","journal-title":"Front Cardiovasc Med"},{"key":"7312_CR6","doi-asserted-by":"publisher","first-page":"109826","DOI":"10.1016\/j.cellsig.2020.109826","volume":"77","author":"A Hanna","year":"2021","unstructured":"Hanna A, Humeres C, Frangogiannis NG. The role of Smad signaling cascades in cardiac fibrosis. Cell Signal. 2021;77:109826.","journal-title":"Cell Signal"},{"key":"7312_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17460441.2020.1690449","volume":"15","author":"KKW To","year":"2020","unstructured":"To KKW, Fong W, Tong CWS, Wu M, Yan W, Cho WCS. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments. Expert Opin Drug Discov. 2020;15:63\u201383.","journal-title":"Expert Opin Drug Discov"},{"key":"7312_CR8","doi-asserted-by":"publisher","first-page":"110546","DOI":"10.1016\/j.biopha.2020.110546","volume":"130","author":"B Zhang","year":"2020","unstructured":"Zhang B, Tian L, Xie J, Chen G, Wang F. Targeting miRNAs by natural products: a new way for cancer therapy. Biomed Pharmacother. 2020;130:110546.","journal-title":"Biomed Pharmacother"},{"key":"7312_CR9","doi-asserted-by":"publisher","first-page":"102912","DOI":"10.1016\/j.ebiom.2020.102912","volume":"59","author":"B Arcidiacono","year":"2020","unstructured":"Arcidiacono B, Chiefari E, Foryst-Ludwig A, et al. Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance. EBioMedicine. 2020;59:102912.","journal-title":"EBioMedicine."},{"key":"7312_CR10","first-page":"60","volume":"37","author":"HA Cakmak","year":"2020","unstructured":"Cakmak HA, Demir M. MicroRNA and cardiovascular diseases. Balkan Med J. 2020;37:60\u201371.","journal-title":"Balkan Med J"},{"key":"7312_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/ijms21010358","volume":"21","author":"B Kura","year":"2020","unstructured":"Kura B, Szeiffova Bacova B, Kalocayova B, Sykora M, Slezak J. Oxidative stress-responsive microRNAs in heart injury. Int J Mol Sci. 2020;21:358.","journal-title":"Int J Mol Sci"},{"key":"7312_CR12","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1002\/jcp.27117","volume":"234","author":"S Huang","year":"2019","unstructured":"Huang S, Zhang L, Song J, et al. Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model. J Cell Physiol. 2019;234:2997\u20133006.","journal-title":"J Cell Physiol"},{"key":"7312_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12012-020-09603-4","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Song JW, Lin JY, Miao R, Zhong JC. Roles of MicroRNA-122 in cardiovascular fibrosis and related diseases. Cardiovasc Toxicol. 2020;20:463\u201373.","journal-title":"Cardiovasc Toxicol"},{"key":"7312_CR14","first-page":"2229","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, Yu T, Zhang S. MicroRNA-489 suppresses isoproterenol-induced cardiac fibrosis by downregulating histone deacetylase 2. Exp Ther Med. 2020;19:2229\u201335.","journal-title":"Exp Ther Med"},{"key":"7312_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0366-6999.196573","volume":"130","author":"M Zhang","year":"2017","unstructured":"Zhang M, Cheng YJ, Sara JD, et al. Circulating MicroRNA-145 is associated with acute myocardial infarction and heart failure. Chin Med J. 2017;130:51\u20136.","journal-title":"Chin Med J"},{"key":"7312_CR16","doi-asserted-by":"publisher","first-page":"15052","DOI":"10.1074\/jbc.RA119.007404","volume":"294","author":"J Wu","year":"2019","unstructured":"Wu J, Huang Q, Li P, et al. MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. J Biol Chem. 2019;294:15052\u201367.","journal-title":"J Biol Chem"},{"key":"7312_CR17","doi-asserted-by":"publisher","first-page":"11603","DOI":"10.18632\/aging.103320","volume":"12","author":"Z Liu","year":"2020","unstructured":"Liu Z, Tao B, Fan S, et al. Over-expression of microRNA-145 drives alterations in beta-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction. Aging (Albany NY). 2020;12:11603\u201322.","journal-title":"Aging (Albany NY)"},{"key":"7312_CR18","doi-asserted-by":"publisher","unstructured":"Xu Z, Sun J, Tong Q, et al. The role of ERK1\/2 in the development of diabetic cardiomyopathy. Int J Mol Sci. 2016;17. https:\/\/doi.org\/10.3390\/ijms17122001","DOI":"10.3390\/ijms17122001"},{"key":"7312_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37\u201340.","journal-title":"Nature."},{"key":"7312_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/liv.12633","volume":"35","author":"T Csak","year":"2015","unstructured":"Csak T, Bala S, Lippai D, et al. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 2015;35:532\u201341.","journal-title":"Liver Int"},{"key":"7312_CR21","doi-asserted-by":"publisher","first-page":"H378","DOI":"10.1152\/ajpheart.00302.2019","volume":"318","author":"E Castillero","year":"2020","unstructured":"Castillero E, Akashi H, Najjar M, et al. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis. Am J Physiol Heart Circ Physiol. 2020;318:H378\u2013H90.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7312_CR22","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.12659\/MSM.898454","volume":"22","author":"Z Yang","year":"2016","unstructured":"Yang Z, Zhang X, Guo N, Li B, Zhao S. Substance P inhibits the collagen synthesis of rat myocardial fibroblasts induced by Ang II. Med Sci Monitor: Int Med J Exp Clin Res. 2016;22:4937\u201346.","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"key":"7312_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/21655979.2016.1227141","volume":"8","author":"X Yang","year":"2017","unstructured":"Yang X, Wang Y, Yan S, et al. Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat. Bioengineered. 2017;8:14\u201320.","journal-title":"Bioengineered"},{"key":"7312_CR24","doi-asserted-by":"publisher","first-page":"102862","DOI":"10.1016\/j.ebiom.2020.102862","volume":"57","author":"M Wolfien","year":"2020","unstructured":"Wolfien M, Klatt D, Salybekov AA, et al. Hematopoietic stem-cell senescence and myocardial repair - coronary artery disease genotype\/phenotype analysis of post-MI myocardial regeneration response induced by CABG\/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT phase 3. EBioMed. 2020;57:102862.","journal-title":"EBioMed"},{"key":"7312_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.17219\/acem\/62915","volume":"26","author":"A Wojciechowska","year":"2017","unstructured":"Wojciechowska A, Braniewska A, Kozar-Kaminska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017;26:865\u201374.","journal-title":"Adv Clin Exp Med"},{"key":"7312_CR26","doi-asserted-by":"publisher","first-page":"172941","DOI":"10.1016\/j.ejphar.2020.172941","volume":"872","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wei X, Zhang W, Wang F, Li Q. MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK\/STAT and MAPK signaling pathways. Eur J Pharmacol. 2020;872:172941.","journal-title":"Eur J Pharmacol"},{"key":"7312_CR27","doi-asserted-by":"publisher","first-page":"173374","DOI":"10.1016\/j.ejphar.2020.173374","volume":"883","author":"JJ Song","year":"2020","unstructured":"Song JJ, Yang M, Liu Y, et al. MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling. Eur J Pharmacol. 2020;883:173374.","journal-title":"Eur J Pharmacol"},{"key":"7312_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10741-019-09770-9","volume":"24","author":"M Dutka","year":"2019","unstructured":"Dutka M, Bobinski R, Korbecki J. The relevance of microRNA in post-infarction left ventricular remodelling and heart failure. Heart Fail Rev. 2019;24:575\u201386.","journal-title":"Heart Fail Rev"},{"key":"7312_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ejhf.495","volume":"18","author":"EL Vegter","year":"2016","unstructured":"Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18:457\u201368.","journal-title":"Eur J Heart Fail"},{"key":"7312_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2017.03.036","volume":"486","author":"D Sun","year":"2017","unstructured":"Sun D, Yang F. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism. Biochem Biophys Res Commun. 2017;486:329\u201335.","journal-title":"Biochem Biophys Res Commun"},{"key":"7312_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-020-0775-5","volume":"115","author":"RK Adapala","year":"2020","unstructured":"Adapala RK, Kanugula AK, Paruchuri S, Chilian WM, Thodeti CK. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation. Basic Res Cardiol. 2020;115:14.","journal-title":"Basic Res Cardiol"},{"key":"7312_CR32","first-page":"105","volume":"106","author":"BF Polegato","year":"2016","unstructured":"Polegato BF, Minicucci MF, Azevedo PS, et al. Association between functional variables and heart failure after myocardial infarction in rats. Arq Bras Cardiol. 2016;106:105\u201312.","journal-title":"Arq Bras Cardiol"},{"key":"7312_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1113\/EP087552","volume":"104","author":"K Wang","year":"2019","unstructured":"Wang K, Zhu ZF, Chi RF, et al. The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure. Exp Physiol. 2019;104:1638\u201349.","journal-title":"Exp Physiol"},{"key":"7312_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia K, Prosdocimo G, Aquaro GD, et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature. 2019;569:418\u201322.","journal-title":"Nature."},{"key":"7312_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021\u201340.","journal-title":"Circ Res"},{"key":"7312_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jcb.29843","volume":"122","author":"S Cui","year":"2021","unstructured":"Cui S, Liu Z, Tao B, et al. miR-145 attenuates cardiac fibrosis through the AKT\/GSK-3beta\/beta-catenin signaling pathway by directly targeting SOX9 in fibroblasts. J Cell Biochem. 2021;122:209\u201321.","journal-title":"J Cell Biochem"},{"key":"7312_CR37","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/acs.molpharmaceut.8b00071","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao L, Ni X, Zhao L, et al. MiroRNA-188 acts as tumor suppressor in non-small-cell lung Cancer by targeting MAP3K3. Mol Pharm. 2018;15:1682\u20139.","journal-title":"Mol Pharm"},{"key":"7312_CR38","first-page":"875","volume":"12","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang Y, Wang S, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Am J Transl Res. 2020;12:875\u201388.","journal-title":"Am J Transl Res"},{"key":"7312_CR39","doi-asserted-by":"publisher","first-page":"1901412","DOI":"10.1002\/advs.201901412","volume":"7","author":"Y Lv","year":"2020","unstructured":"Lv Y, Huang Y, Xu M, et al. The miR-193a-3p-MAP3k3 signaling Axis regulates substrate topography-induced Osteogenesis of bone marrow stem cells. Adv Sci (Weinh). 2020;7:1901412.","journal-title":"Adv Sci (Weinh)"},{"key":"7312_CR40","doi-asserted-by":"publisher","first-page":"37705","DOI":"10.18632\/oncotarget.17144","volume":"8","author":"C Yu","year":"2017","unstructured":"Yu C, Liu Y, Sun L, et al. Chronic obstructive sleep apnea promotes aortic remodeling in canines through miR-145\/Smad3 signaling pathway. Oncotarget. 2017;8:37705\u201316.","journal-title":"Oncotarget."},{"key":"7312_CR41","doi-asserted-by":"publisher","first-page":"e23385","DOI":"10.1002\/dvg.23385","volume":"58","author":"D Sawant","year":"2020","unstructured":"Sawant D, Klevenow E, Baeten JT, et al. Generation of transgenic mice that conditionally express microRNA miR-145. Genesis. 2020;58:e23385.","journal-title":"Genesis."}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07312-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-021-07312-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07312-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T10:15:30Z","timestamp":1690971330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-021-07312-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["7312"],"URL":"https:\/\/doi.org\/10.1007\/s10557-021-07312-w","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"29 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee on the Experimental Animal Care and Use Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}